programmed ventricular stimulation was used to assess the effect of oral disopyramide ( 600 mg/day ) , mexiletine ( 600 -- 1000 mg/day ) , and a combination of both drugs in a randomized cross-over study on 12 patients with documented ventricular tachycardia and/or fibrillation .
C0012702
disopyramide
C0042514
ventricular tachycardia